1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 08 JUNE 2015

Cancer Drug News 08 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Janssen's Daratumumab Set To Enter MM Market In 2016
Industry Brief - TapImmune Gains Funding Options For Phase II Trial Programmes
Industry Brief - Amgen/Roche Enter Immuno-Oncology Trial Collaboration
Industry Trend Analysis - First-Line CLL Signifies Start Of Imbruvica Market Expansion
Industry Brief - Aptose's APTO253 Granted ODD In US For AML
Industry Brief - AVEO Receives EU Regulatory Guidance On Tivozanib MAA
Industry Brief - PharmaEngine Seeks Approval For MM-398 In Taiwan
Industry Brief - CEL-SCI Cleared To Start Multikine Phase III H&N Cancer Trial In Thailand
Industry Trend Analysis - BMS Faces Heated Battle For Position In Anti-PD-1 Space
Industry Brief - Seattle/Unum Enter Cancer Immunotherapy Collaboration
Industry Brief - Celgene/bluebird Decrease CAR-T Deal Remit
Industry Brief - Merck/Agenus Extend Immuno-Oncology Collaboration
Industry Trend Analysis - Merck's Recent Immuno-Oncology Efforts Will Increase Competitive Edge
Industry Brief - Genmab Gains License To Antibody Panel Targeting CD19 From BMS
Industry Brief - Merck Enters Immuno-Oncology Trial Collaborations With Amgen/Tesaro/Dynavax
Industry Trend Analysis - Novartis Will Make Tafinlar/Mekinist A Blockbuster
Industry Brief - Abraxis Denied Patent On Abraxane In India
Industry Trend Analysis - Global CINV Drugs Market On Course To Grow
Industry Brief - Heron Reports Positive Results From Phase III MAGIC Study Of Sustol
Industry Brief - Juno Adds Antibody Engineering Capabilities Through X-BODY Acquisition
Industry Brief - DARA Proposes Acquisition Of UK-Based Midatech Pharma

Table Of Contents

Cancer Drug News 08 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.